%PDF-1.3
%
4 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
3 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
7 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
8 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
5 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
1 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
6 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T0WI2P0T5T R
Ɩf
!\!Y\ !p
o
endstream
endobj
10 0 obj
<>stream
2021-02-27T14:39+05:30
Arbortext Advanced Print Publisher 9.0.114/W
2021-03-18T04:54:51-07:00
Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT
application/pdf
DIA-2020-0667-ver9-Yamamoto_3P 8..14
uuid:e4b82263-dcba-448f-af5c-e19b4545a583
uuid:f26705ae-3c86-4641-ae9f-7e1833a7f931
endstream
endobj
11 0 obj
<>stream
x+ |
endstream
endobj
12 0 obj
<>stream
xS**T0T0 Bi yS&
endstream
endobj
13 0 obj
<>stream
x+ |
endstream
endobj
14 0 obj
<>stream
xS**T0T0 Bi y\'
endstream
endobj
15 0 obj
<>stream
x+ |
endstream
endobj
16 0 obj
<>stream
xS**T0T0 Bi yJ%
endstream
endobj
17 0 obj
<>stream
x+ |
endstream
endobj
18 0 obj
<>stream
xS**T0T0 Bi yn)
endstream
endobj
19 0 obj
<>stream
x+ |
endstream
endobj
20 0 obj
<>stream
xS**T0T0 Bi y8#
endstream
endobj
21 0 obj
<>stream
x+ |
endstream
endobj
22 0 obj
<>stream
xS**T0T0 Bi yA$
endstream
endobj
23 0 obj
<>stream
x+ |
endstream
endobj
24 0 obj
<>stream
xS**T0T0 Bi ye(
endstream
endobj
26 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
9.843 0 0 9.843 59.7543 725.1588 Tm
0 0 0 rg
.0131 Tc
0 Tw
[(obs)6.4(te)5.1(tri)6.1(c)-185(an)6.2(d)-183.8(n).5(e)5.1(o).5(n)6.2(a)-.7(t)6.1(a)-.7(l)-184(o).5(u)6.2(t).4(c)5.1(o).5(m)5(e)-.7(s)-183.6(i)6.1(n)-183.8(d).5(i)6.1(a)-.7(be)5.1(te)5.1(s)-183.6(p).5(r)6.3(e)-.7(gn)6.2(an)6.2(ci)6.1(es)-183.6(an)6.2(d)]TJ
0 -1.1174 TD
0 Tc
[(to)-319.1(ex)19.7(am)18.5(in)20.7(e)-330.6(t)0(h)20.7(e)-330.6(hi)20.7(gh)20.8(-q)15.1(ua)19.7(li)20.6(ty)20.7(,)-326(r)0(a)14(n)0(d)20.8(o)0(m)19.6(i)0(z)19.6(e)0(d)19.7(-)0(c)19.7(o)0(n)15.1(t)0(r)20.7(o)0(l)20.7(l)0(e)19.6(d)-329.4(tr)20.7(ia)19.6(l)-329.5(a)0(n)19.7(d)]TJ
0 -1.1116 TD
[(th)15(e)-203.8(r)0(e)19.7(a)0(l)19.5(-)0(w)20(o)0(r)20.9(l)0(d)-192.4(c)0(l)13.8(i)0(n)20.7(i)0(c)19.5(a)0(l)-193.6(d)0(a)19.7(t)0(a)-193.6(e)0(v)19.7(a)0(l)19.5(u)0(a)19.7(t)0(i)14.8(n)0(g)-192.3(t)0(h)20.7(e)-203.8(im)19.5(pa)19.7(ct)-193.6(of)-192.2(CG)18.9(M)-203.6(u)0(s)21(e)0(.)]TJ
/F4 1 Tf
8.9663 0 0 8.9663 59.7543 675.7794 Tm
[(The)-325.5(Changing)-329.9(Landscape)-322.9(of)-323.9(Diabetes)-329(in)-319(Pregnancy)]TJ
/F5 1 Tf
9.843 0 0 9.843 69.7323 659.3384 Tm
[(The)-259.1(prevalence)-264.6(of)-261.4(gestational)-263.6(diabetes)-260(and)-257.9(of)-261.4(pregnancies)]TJ
-1.0137 -1.1116 TD
[(complicated)-352.5(by)-342(type)-345.5(1)-346.7(o)0(r)-347.7(type)-345.5(2)-340.9(diabetes)-352.2(has)-344.1(doubled)-348.8(over)]TJ
T*
[(recent)-280.9(decades,)-274.8(such)-276.1(that)-276.5(by)-272.9(the)-275.3(age)-270.6(of)-278.6(30)-272.9(years,)-276(almost)-274(1)-271.8(i)0(n)]TJ
0 -1.1174 TD
[(10)-290.2(women)-296.8(is)-290.1(affected)-295.8(by)-284.4(hyperglycemia)-296.9(in)-290.3(pregnancy.)]TJ
7.3823 0 0 6.5614 276.9448 630.8786 Tm
(3)Tj
9.843 0 0 9.843 283.5212 626.4565 Tm
(The)Tj
-22.7336 -1.1116 TD
[(increasing)-498.4(prevalence)-495(of)-486(pregnancies)-494.7(complicated)-496.4(by)-486(hy-)]TJ
T*
[(perglycemia)-208.3(is)-203.7(apparent)-208.2(across)-204.3(all)-206.3(types)-202.4(of)-203.8(diabetes,)-205.9(affecting)]TJ
T*
[(not)-205(only)-206.1(women)-204.6(with)-201.4(gestational)-211.8(and)-200.3(type)-207.3(2)-202.7(diabetes,)-205.9(but)-205(also)]TJ
0 -1.1174 TD
[(women)-210.4(with)-201.4(type)-207.3(1)-202.7(diabetes,)-205.9(in)-203.9(whom)-208.1(increases)-204.3(of)-203.8(30%40%)]TJ
0 -1.1116 TD
[(have)-375.3(been)-375.4(reported)-374.1(across)-371.4(Northern)-373.8(Europe.)]TJ
7.3823 0 0 6.5614 239.4708 576.0565 Tm
(4)Tj
9.843 0 0 9.843 246.7842 571.6912 Tm
[(It)-370.9(is)-376.5(well)-369.6(es-)]TJ
-19.0013 -1.1116 TD
[(tablished)-444.4(that)-437.8(pregnant)-437.5(women)-440.8(with)-437.5(type)-437.7(1)-438.8(diabetes)-444.3(have)]TJ
0 -1.1174 TD
[(higher)-330.4(and)-332.8(more)-329.3(variable)-329.3(glucos)-7.7(e)-324.8(levels,)-335(are)-328.1(more)-329.3(likely)-330.7(to)]TJ
0 -1.1116 TD
[(have)-283.2(impaired)-289.1(awareness)-285.7(to)-278.8(hypoglycemia,)-286.6(increased)-285.2(day)-280.9(to)]TJ
T*
[(day)-361.6(hypoglycemic)-363.8(events,)-363.6(and)-361.6(increased)-360.1(risk)-361.4(of)-359.3(severe)-361.2(hy-)]TJ
0 -1.1174 TD
[(poglycemia,)-301.7(and)-292.4(thus)-298.1(spend)-294.5(less)-293.3(time)-295(with)-293.5(glucos)-7.7(e)-290.2(levels)-297(in)]TJ
0 -1.1116 TD
[(the)-309.9(pregnancy)-312.9(target)-314.4(range)-313.1(compared)-313(with)-310.8(pregnant)-310.7(women)]TJ
T*
[(with)-316.6(type)-316.7(2)-312.1(diabetes.)-315.3(For)-314.1(women)-319.8(with)-310.8(type)-316.7(1)-312.1(diabetes,)-315.3(who)]TJ
0 -1.1174 TD
[(lack)-496.4(biologically)-494.3(active)-494.2(pancreatic)-495.1(insulin)-491.7(secretion,)-494.9(it)-492(is)]TJ
25.5097 24.5018 TD
[(particularly)-305.1(challenging)-309.7(to)-301.8(balance)-306.2(the)-304.1(achieveme)-11.3(nt)-301.8(of)-301.7(tight)]TJ
0 -1.1174 TD
[(pregnancy)-335.9(glucose)-338.3(targets)-338.4(with)-333.8(the)-338.7(risk)-332.6(of)-336.2(daily)-335.2(and)-332.8(severe)]TJ
0 -1.1116 TD
-.0276 Tc
[(hypoglycemic)-375.4(e)-1.1(vents.)-370.9(Consequently,)-370.9(only)-374.3(a)-369.7(minority)-374.3(\()]TJ
/F10 1 Tf
21.236 0 TD
0 Tc
(*)Tj
/F5 1 Tf
.9734 0 TD
-.0293 Tc
(15%\))Tj
-22.2094 -1.1116 TD
-.0276 Tc
[(are)-219.9(a)-1.1(ble)-219.9(t)5.7(o)-224.5(a)4.7(chieve)-219.9(the)-219.9(r).1(ecommended)-218.8(h).1(emoglobin)-218.8(A)-.8(1C)-219.8(\(HbA1c\))]TJ
T*
0 Tc
[(target)-285.6(of)-284.4(below)-289.9(48)-163.5(mmol)-7(/mol)-288.1(\(6.5%\))-286.4(in)-278.8(early)-290.1(pregna)-8.9(ncy.)]TJ
7.3823 0 0 6.5614 536.2581 685.7006 Tm
(5)Tj
9.843 0 0 9.843 320.8251 670.3369 Tm
[(Nationwide)-510.8(population-)-7.9(based)-514.5(data)-513.7(from)-512.4(8685)-511.3(pregnant)]TJ
-1.0137 -1.1116 TD
[(women)-308.3(with)-305(type)-305.2(1)-306.4(diabetes)-311.9(demonstrate)-310.6(that)-305.3(younger)-308.4(aged)]TJ
T*
[(women)-331.3(\(younger)-338.2(than)-334(25)-336.3(years\),)-334.6(those)-334.9(with)-333.8(more)-335.1(than)-334(a)-336.3(5)0(-)]TJ
0 -1.1174 TD
[(year)-479(duration)-482.5(of)-480.2(diabetes,)-482.3(higher)-480.2(body)-476.7(mass)-484.5(index)-479.1(\(BMI)]TJ
/F8 1 Tf
0 -1.1116 TD
(>)Tj
/F5 1 Tf
.5529 0 TD
[(25)-163.5(kg/m)]TJ
7.3823 0 0 6.5614 348.0377 630.8786 Tm
(2)Tj
9.843 0 0 9.843 351.7794 626.5132 Tm
[(\),)-396.2(and)-401.9(living)-398.7(in)-399.7(all)-402.1(except)-401.9(for)-400.7(the)-396.3(least)-405.3(deprived)]TJ
-4.1585 -1.1116 TD
[(regions)-221.9(are)-224.5(unlikely)-223.5(to)-221.2(achieve)-225.6(glycemic)-221.1(targets.)]TJ
7.3823 0 0 6.5614 500.4849 619.9368 Tm
(6)Tj
9.843 0 0 9.843 506.3242 615.5715 Tm
[(Indeed,)-225.4(the)]TJ
-19.8595 -1.1174 TD
[(women)-446.5(most)-443.3(likely)-451.7(to)-440.1(achieve)-450.2(target)-452.7(HbA1c)-446.2(levels)-446.7(using)]TJ
0 -1.1116 TD
[(SMBG)-490.9(are)-495.2(those)-490.4(aged)-490.5(3544)-495.1(years)-491.4(\(who)-494.8(generally)-491.7(have)]TJ
T*
[(higher)-203.7(incomes,)-204.7(education)-209.5(and)-200.3(health)-205(literacy\))-209.5(and)-206.1(those)-202.4(with)]TJ
T*
[(the)-344.4(shortest)-349.6(duration)-350(of)-347.7(diabetes)-352.2(\()]TJ
/F8 1 Tf
13.8809 0 TD
(<)Tj
/F5 1 Tf
.5529 0 TD
[(1)-346.7(year\))-347.6(who)-349.8(likely)-348(have)]TJ
-14.4338 -1.1174 TD
[(residual)-281.9(pancreatic)-287.8(insulin)-278.6(secretion)-284.1(\(Table)-286.7(1\).)]TJ
7.3823 0 0 6.5614 495.666 565.1148 Tm
(6)Tj
9.843 0 0 9.843 320.8251 549.8077 Tm
-.0158 Tc
[(In)-316.4(co)-15.8(n)10.8(t).3(ra)-15.8(s)9.8(t)-316.5(t)-15.8(o)-306.1(pr)-15.8(e)9.7(v).4(iou)-15.8(s)-305.8(da)-15.8(t)9.5(a)-317.6(s)-15.8(u)11(gges)-15.8(t)10.9(ing)-322.2(s).6(ub)-15.8(s)11(t).2(an)-15.8(t)10.7(i).2(al)-322.3(clin)-15.8(i)10.7(c)-317.6(to)]TJ
-1.0137 -1.1116 TD
0 Tc
[(c)15(l)16.1(i)16.1(n)0(i)26.5(c)-359.4(v)16.2(a)15(r)16.2(i)16(at)25.3(i)16.1(o)16.2(n,)-344.4(t)16.1(h)16.2(is)-341.9(la)25.3(r)16.2(g)16.2(e)-359.4(c)15(o)16.2(ho)26.6(r)16.2(t)-358.3(d)16.2(e)15(m)15(o)0(n)26.6(s)16.4(t)16.1(r)0(a)25.5(t)16(e)15(d)-358.2(t)16(h)16.2(at)-343.3(af)25.5(t)16(e)15(r)-358.2(a)15(d)16.2(-)]TJ
0 -1.1174 TD
-.0156 Tc
[(jus)-15.6(t)11.1(ing)-339.2(f)-15.6(o)11(r)-339.2(mat)-15.6(e)9.7(rna)-15.6(l)-330.1(d).6(emo)-15.6(g)11(r).6(aph)-15.6(i)10.9(c)-340.4(a)-.6(nd)-345(clin)-15.6(i)10.9(cal)-339.4(c)-15.6(h)9.8(arac)-15.6(t)9.7(e)-.6(ri)-15.6(s)11.1(t).5(ic)-15.6(s)10(,)]TJ
0 -1.1116 TD
[(ther)-15.7(e)-364.6(w)-.4(as)-379.5(no)-373.9(ev)-15.7(i)10.8(d).5(en)-15.7(c)9.7(e)-375.1(of)-379.6(stat)-15.7(i)10.6(s).7(ti)-15.7(c)9.6(a)-.7(lly)-379.7(sign)-15.7(i)10.8().6(ca)-15.7(n)9.7(t)-374(va)-15.7(r)9.8(i).4(ati)-15.7(o)10.8(n)-373.9(i).3(n)]TJ
T*
[(mater)-15.7(n)10.9(a)-.7(l)-293.4(g).5(lyc)-15.7(e)8.6(mia)-294.4(b).5(etw)-15.7(e)8.9(en)-293.3(clini)-15.7(c)9.6(s,)-289.8(e)-15.7(i)9.6(ther)-293.2(in)-293.3(ear)-15.7(l)10.8(y)-293.3(or)-287.5(l)-15.7(a)9.6(te)-294.4(ges-)]TJ
0 -1.1174 TD
-.0158 Tc
[(tati)-15.8(o)10.7(n).4(.)]TJ
7.3823 0 0 6.5614 334.8282 499.4077 Tm
-.0179 Tc
(5,6)Tj
9.843 0 0 9.843 345.9967 494.9857 Tm
-.0158 Tc
[(In)-241.5(add)-15.8(i)10.7(tio)-15.8(n)10.8(,)-238.1(t).3(h)-15.8(e)-226.5(a)-15.8(l)9.5(read)-15.8(y)-225.3(h)-15.8(i)10.7(g).4(h)-241.5(r).4(at)-15.8(e)9.5(s)-241.3(of)-241.5(pre)-15.8(t)9.5(e)-.8(rm)-242.8(del)-15.8(i)10.5(very)]TJ
-3.571 -1.1116 TD
-.0159 Tc
[(\(bef)-15.9(o)10.7(re)-260.1(37)-264.7(weeks)-15.9(\))-248.3(and)-258.9(o).3(f)-264.6(l).2(arge)-15.9(-)9.6(for)-15.9(-)10.8(g).3(es)-15.9(t)10.8(a)-.9(ti)-15.9(o)10.6(n).3(al-)-15.9(a)9.6(ge)-260.1(bi)-15.9(r)10.6(t).2(hw)-15.9(e)8.7(i).1(ght)]TJ
ET
59.754 440.561 490.167 .22678 re
f
59.754 140.145 490.167 .22676 re
f
59.754 421.682 230.57 .22681 re
f
332.561 421.682 217.361 .22681 re
f
59.754 403.994 490.167 .22678 re
f
BT
/F7 1 Tf
9.845 0 0 9.845 136.233 456.2078 Tm
0 Tc
(Table)Tj
/F5 1 Tf
3.0002 0 TD
(1.)Tj
/F7 1 Tf
1.2496 0 TD
[(Factors)-334.5(Associated)-332.5(with)-334.7(Target)-335(Glycemia)-332(\(Hemoglobin)]TJ
/F5 1 Tf
25.9019 0 TD
(A1C)Tj
/F7 1 Tf
2.2228 0 TD
(Less)Tj
-25.8156 -1.0135 TD
(than)Tj
/F5 1 Tf
2.6144 0 TD
(6.5)Tj
/F7 1 Tf
1.2496 0 TD
.336 Tc
(%[)Tj
/F5 1 Tf
1.503 0 TD
0 Tc
(48)Tj
/F7 1 Tf
1.1632 0 TD
[(mmol/mol]\))-340.9(in)-331.6(Early)-334(Pregnancy)]TJ
/F11 1 Tf
-20.8575 -1.8427 TD
[(Type)-340.1(1)-329.2(diabetes)-338.7(pregnancy)-22217.2(Type)-334.4(2)-335(diabetes)-338.7(pregnancy)]TJ
0 -1.8139 TD
[(Category)-11142.5(Odds)-332.8(ratio)-333.4(\(95%)-333.2(CI\))-7046.7(Category)-7048.2(Odds)-338.6(ratio)-333.4(\(95%)-333.2(CI\))]TJ
/F5 1 Tf
0 -1.9003 TD
[(Maternal)-340.8(age)-333.6(category)]TJ
7.3837 0 0 6.5625 149.8393 395.9432 Tm
(a)Tj
9.845 0 0 9.845 332.5605 391.5212 Tm
(Ethnicity)Tj
7.3837 0 0 6.5625 368.844 395.9432 Tm
(e)Tj
9.845 0 0 9.845 59.7543 381.5999 Tm
[(Age)-339(1524)-333.2(years)-8817.7(0.32)-334.6(\(0.250.40\))-5192.6(Ethnicity)-334.4(N/A)-8694.4(0.99)-328.8(\(0.791.24\))]TJ
0 -1.0135 TD
[(Age)-339(3544)-333.2(years)-8817.7(1.30)-334.6(\(1.111.52\))-5192.6(Unknown)-10494.9(1.79)-328.8(\(1.162.76\))]TJ
T*
(Age)Tj
/F8 1 Tf
2.004 0 TD
(>)Tj
/F5 1 Tf
.5528 0 TD
[(45)-330.2(years)-9767.9(2.14)-334.6(\(0.657.13\))-5192.6(Mixed)-11817.9(1.10)-328.8(\(0.761.58\))]TJ
25.1533 -1.0135 TD
[(Asian)-12099.9(0.72)-328.8(\(0.640.82\))]TJ
0 -1.0077 TD
[(Black)-12089.9(0.72)-328.8(\(0.590.88\))]TJ
0 -1.0135 TD
[(Other)-12151.9(0.86)-328.8(\(0.611.20\))]TJ
-27.7101 -1.0135 TD
[(Maternal)-340.8(deprivation)-336.2(quintile)]TJ
7.3837 0 0 6.5625 177.2787 326.1542 Tm
(b)Tj
9.845 0 0 9.845 69.6189 311.8676 Tm
[(Deprivation)-337.1(N/A)-7922.8(0.70)-334.6(\(0.510.96\))-5192.6(Deprivation)-337.1(N/A)-7588.8(0.99)-328.8(\(0.731.34\))]TJ
T*
[(Quintile)-333.1(5)-10642.8(0.44)-334.6(\(0.350.55\))-5192.6(Quintile)-333.1(5)-10308.8(0.73)-328.8(\(0.570.93\))]TJ
T*
[(Quintile)-333.1(4)-10642.8(0.48)-334.6(\(0.390.60\))-5192.6(Quintile)-333.1(4)-10308.8(0.84)-328.8(\(0.651.07\))]TJ
T*
[(Quintile)-333.1(3)-10642.8(0.65)-334.6(\(0.530.80\))-5192.6(Quintile)-333.1(3)-10308.8(1.01)-328.8(\(0.781.30\))]TJ
0 -1.0077 TD
[(Quintile)-333.1(2)-10642.8(0.67)-334.6(\(0.540.82\))-5192.6(Quintile)-333.1(2)-10308.8(1.09)-328.8(\(0.821.45\))]TJ
-1.002 -1.3187 TD
[(Diabetes)-340.7(duration)]TJ
1.002 -1.0135 TD
[(Diabetes)-334.9(duration)-337.7(N/A)]TJ
7.3837 0 0 6.5625 160.5543 253.4739 Tm
(c)Tj
9.845 0 0 9.845 214.9795 249.0519 Tm
[(0.76)-334.6(\(0.381.51\))-5192.6(Diabetes)-334.9(duration)-337.7(N/A)-5193.2(0.79)-328.8(\(0.591.06\))]TJ
-14.7649 -1.0077 TD
(Duration)Tj
/F8 1 Tf
3.8985 0 TD
(<)Tj
/F5 1 Tf
.5471 0 TD
[(1)-335(year)-7757.3(1.69)-334.6(\(1.112.57\))-5192.6(Duration)]TJ
/F8 1 Tf
26.1553 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
[(1)-335(year)-7423.3(0.86)-328.8(\(0.721.02\))]TJ
-31.1537 -1.0135 TD
[(Duration)-338.5(59)-331.2(years)-6923.1(0.54)-334.6(\(0.430.67\))-5192.6(Duration)-332.7(59)-337(years)-6589.1(0.60)-328.8(\(0.520.68\))]TJ
T*
[(Duration)-338.5(1014)-333.2(years)-5921.1(0.40)-334.6(\(0.320.50\))-5192.6(Duration)-332.7(1014)-333.2(years)-5592.9(0.48)-328.8(\(0.390.60\))]TJ
0 -1.0077 TD
(Duration)Tj
/F8 1 Tf
3.8985 0 TD
(>)Tj
/F5 1 Tf
.5471 0 TD
[(15)-336(years)-6871.3(0.43)-334.6(\(0.360.52\))-5192.6(Duration)]TJ
/F8 1 Tf
26.1553 0 TD
(>)Tj
/F5 1 Tf
.5528 0 TD
[(15)-336(years)-6537.3(0.41)-328.8(\(0.270.61\))]TJ
-32.1557 -1.3187 TD
[(BMI)-338.8(\(kg/m)]TJ
7.3837 0 0 6.5625 105.222 200.6361 Tm
(2)Tj
9.845 0 0 9.845 108.9071 196.2708 Tm
(\))Tj
-3.9907 -1.0135 TD
(BMI)Tj
/F8 1 Tf
2.217 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
(18.5)Tj
7.3837 0 0 6.5625 114.1228 190.7149 Tm
(d)Tj
9.845 0 0 9.845 214.9795 186.2929 Tm
[(1.27)-334.6(\(0.712.29\))-5192.6(BMI)]TJ
/F8 1 Tf
14.1603 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
[(18.5)-9911(0.86)-328.8(\(0.362.10\))]TJ
-29.478 -1.0077 TD
[(BMI)-333(2529.9)-9297.8(0.75)-334.6(\(0.640.87\))-5192.6(BMI)-333(2529.9)-8963.8(0.80)-328.8(\(0.660.97\))]TJ
0 -1.0135 TD
[(BMI)-333(3034.9)-9297.8(0.63)-334.6(\(0.510.77\))-5192.6(BMI)-333(3034.9)-8963.8(0.65)-328.8(\(0.540.79\))]TJ
T*
[(BMI)-333(3539.9)-9297.8(0.55)-334.6(\(0.390.78\))-5192.6(BMI)-333(3539.9)-8963.8(0.55)-328.8(\(0.450.68\))]TJ
T*
(BMI)Tj
/F8 1 Tf
2.217 0 TD
(>)Tj
/F5 1 Tf
.5528 0 TD
[(40)-10995(0.53)-334.6(\(0.310.90\))-5192.6(BMI)]TJ
/F8 1 Tf
26.1553 0 TD
(>)Tj
/F5 1 Tf
.5528 0 TD
[(40)-10661(0.52)-328.8(\(0.420.64\))]TJ
8.7511 0 0 8.7511 67.748 128.3527 Tm
[(Separate)-322.9(models)-325.8(were)-328.9(run)-319(for)-324(type)-325.6(1)-322.8(and)-321.6(type)-325.6(2)-322.8(diabetes.)-323.1(Only)-326.7(factors)-325.3(that)-324.4(were)-322.4(signicant)-328.5(in)-320.3(univariate)-323.5(analyses)-326.6(were)-328.9(retained)-320.6(in)-326.8(the)]TJ
-.9134 -1.0301 TD
[(multivariate)-335.7(analyses.)-335.7(N/A)-336.6(is)-331.7(data)-333.3(not)-332.1(available.)]TJ
6.5633 0 0 5.8334 67.748 114.2928 Tm
(a)Tj
8.7511 0 0 8.7511 70.696 110.3811 Tm
[(Reference)-338.3(group)-329.6(for)-330.5(maternal)-337.6(age)-335.7(category)-328.4(at)-334.5(delivery)-332.4(is)-338.1(2534)-331.1(years.)-333(Maternal)-337.3(age)-329.3(category)-334.9(did)-332.1(not)-332.1(improve)-337.7(the)-333.3(model)-328.5(t)-333.1(in)-333.3(type)-332.1(2)]TJ
-1.2503 -1.0236 TD
[(diabetes)-339.9(and)-328.1(is)-338.1(therefore)-330.8(omitted.)]TJ
6.5633 0 0 5.8334 67.748 96.3779 Tm
(b)Tj
8.7511 0 0 8.7511 71.0362 92.4661 Tm
[(Reference)-338.3(group)-329.6(for)-330.5(maternal)-337.6(deprivation)-334.1(quintile)-330.2(is)-331.7(the)-333.3(least)-335.7(deprived)-333.7(quintile)-336.6(1.)]TJ
6.5633 0 0 5.8334 67.748 87.3637 Tm
(c)Tj
8.7511 0 0 8.7511 70.696 83.5086 Tm
[(Reference)-338.3(group)-329.6(for)-330.5(diabetes)-339.9(duration)-331.2(is)-331.7(duration)-331.2(14)-333.4(years.)]TJ
6.5633 0 0 5.8334 67.748 78.4063 Tm
(d)Tj
8.7511 0 0 8.7511 71.0362 74.5512 Tm
[(Reference)-338.3(group)-329.6(for)-330.5(maternal)-337.6(BMI)-331.6(is)-331.7(the)-333.3(healthy)-335(BMI)-331.6(range)-338.4(of)-333.1(18.524.9.)]TJ
6.5633 0 0 5.8334 67.748 69.4488 Tm
(e)Tj
8.7511 0 0 8.7511 70.696 65.5937 Tm
[(Reference)-338.3(group)-329.6(for)-330.5(maternal)-337.6(ethnicity)-330.2(is)-338.1(white.)]TJ
-.3369 -1.0301 TD
[(BMI,)-334.3(body)-332.2(mass)-334.2(index.)]TJ
/F4 1 Tf
8.9663 0 0 8.9663 59.7543 749.7069 Tm
[(BENEFITS)-336.7(OF)-337.5(REAL-TIME)-336.2(CGM)-336.3(IN)-335.1(PREGNANCY)-29956.2(S-9)]TJ
ET
endstream
endobj
38 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
9.843 0 0 9.843 62.022 725.1588 Tm
0 0 0 rg
0 Tc
0 Tw
[(i)16.1(n)-150.8(ty)26.5(p)16.2(e)-152(1)-150.8(d)0(i)26.5(a)15(b)16.2(e)15(te)25.3(s)-150.7(p)16.2(re)25.5(g)16.2(n)16.2(a)15(nc)25.4(y)-150.8(a)15(l)16.1(s)0(o)-140.2(s)16.4(e)15(e)0(m)-137.1(t)0(o)-140.6(b)16.2(e)-152(i)16.1(nc)25.4(r)16.2(e)15(a)15(s)0(i)26.7(n)16.2(g)-150.8(i)0(n)-140.6(r)16.2(e)15(c)15(e)0(n)25.4(t)]TJ
0 -1.1174 TD
-.0157 Tc
[(yea)-15.7(r)9.8(s)-350.7(a)-.7(n)-15.7(d)-340.4(thes)-15.7(e)-341.4(p).5(at)-15.7(t)10.6(e)-.7(rn)-15.7(s)-340.2(a)-.7(re)-352(a)-15.7(l)9.6(so)-350.9(a)-15.7(p)9.7(pare)-15.7(n)9.7(t)-351(acr)-15.7(o)10.9(s).7(s)-356.4(a)-.7(ll)-351(di)-15.7(a)9.6(b).5(ete)-15.7(s)]TJ
0 -1.1116 TD
[(pr)-15.8(e)9.7(gnan)-15.8(c)9.6(y)-293.4(c)-.8(li)-15.8(n)10.7(i).3(cs)-298.9(and)-293.4(w)-15.8(i)9.8(t).3(hou)-15.8(t)-283.1(s).6(u)-15.8(b)10.8(stan)-15.8(t)10.7(i).3(al)-299.3(clin)-15.8(i)10.7(c)-294.5(to)-293.4(c)-15.8(l)9.5(ini)-15.8(c)-284.2(vari)-15.8(-)]TJ
T*
[(at)-15.7(i)10.6(on.)]TJ
7.3823 0 0 6.5614 83.3952 696.6423 Tm
0 Tc
(6)Tj
9.843 0 0 9.843 91.1055 692.277 Tm
[(T)15(h)16.2(u)16.2(s)16.4(,)-406.6(n)16.2(ew)-395.9(i)16.1(n)16.2(te)25.3(r)16.2(v)16.2(e)15(nt)26.5(i)16.1(o)16.2(ns)-393.7(t)16.1(o)-404.3(sa)25.6(f)16.2(e)15(l)16.1(y)-410(o)16.2(p)16.2(t)16.1(im)25.2(i)16.1(z)15(e)-405.4(a)15(nt)26.5(e)15(n)16.2(a)15(t)0(a)25.3(l)]TJ
-2.9547 -1.1116 TD
[(g)16.2(l)0(u)26.5(c)15(o)16.2(s)0(e)-204.8(l)16.1(e)15(v)16.2(el)25.3(s)-214(a)15(nd)-203.8(r)16.2(e)0(d)25.4(u)16.2(c)15(e)-215.4(ob)26.6(s)16.4(t)16.1(et)25.3(r)16.2(i)16.1(c)-221.1(a)15(n)16.2(d)-214.2(ne)25.4(o)16.2(n)16.2(a)15(ta)25.3(l)-214.3(c)15(om)25.4(p)16.2(l)16.1(i)16.1(c)0(a)24.3(t)16.1(i)16.1(o)16.2(ns)]TJ
0 -1.1174 TD
-.0158 Tc
[(ar)-15.8(e)-295.6(n).4(ee)-15.8(d)9.6(e)-.8(d,)-307.2(fo)-15.8(r)-294.4(a)-.8(l)-15.8(l)-294.7(pre)-15.8(g)9.6(n).4(ant)-310.8(w)-.5(ome)-15.8(n)-295.6(wit)-15.8(h)-294.6(ty)-15.8(p)10.8(e)-306(1)-310.6(d).4(iabe)-15.8(t)9.5(e)-.8(s,)-307.2(a)-15.8(n)9.6(d)]TJ
0 -1.1116 TD
[(th)-15.7(e)9.7(s).7(e)-254.1(s).7(hou)-15.7(l)10.8(d)-252.9(be)-248.3(i)-15.7(m)9.5(pleme)-15.7(n)9.7(t).4(ed)-252.9(acro)-15.7(s)11.1(s)-252.7(a)-.7(ll)-253.1(mater)-15.7(n)10.9(ity)-252.9(cli)-15.7(n)10.8(ics)-15.7(.)]TJ
/F4 1 Tf
8.9663 0 0 8.9663 62.022 631.899 Tm
0 Tc
[(Growing)-337.1(Evidence)-333.9(Supporting)-335.3(CGM)-336.3(Use)]TJ
0 -1.2203 TD
[(in)-331.6(Pregnancy)]TJ
/F5 1 Tf
9.843 0 0 9.843 72 604.5164 Tm
[(The)-339.7(CONCEPTT)-338.6(\(CGM)-341.2(in)-336.4(pregnant)-339.5(women)-337.1(with)-339.6(type)-339.8(1)]TJ
-1.0137 -1.1116 TD
[(diabetes\))-295.7(trial)-300.8(provided)-292.3(high-quality,)-294.8(randomized-cont)-11.1(rolled)]TJ
0 -1.1174 TD
[(trial)-323.8(data)-323.6(demonstrating)-323.3(that)-322.6(the)-321.4(use)-321.1(of)-319(real-time)-326(CGM)-322.9(was)]TJ
0 -1.1116 TD
[(associated)-389.9(with)-379.9(lower)-387.8(HbA1c)-382.8(at)-383.6(34)-382.3(weeks,)-386.3(suggesting)-386.4(im-)]TJ
T*
[(proved)-382.1(maternal)-388.1(glucose)-384.4(levels)-383.4(during)-381.1(the)-384.7(late)-381.4(second)-383.1(and)]TJ
T*
[(early)-221(third)-213.1(trimesters.)]TJ
7.3823 0 0 6.5614 146.1543 554.1164 Tm
(7)Tj
9.843 0 0 9.843 151.937 549.751 Tm
[(Importantly,)-219.9(this)-217.6(was)-218.3(accompanied)-220.9(by)]TJ
-9.1349 -1.1174 TD
[(7%)-406.4(higher)-411.1(time)-404.5(in)-405.5(range)-411(\(TIR\))-405.1(and)-407.6(5%)-406.4(lower)-410.8(time)-410.2(above)]TJ
0 -1.1116 TD
[(range)-555(\(TAR\))-550(without)-550.4(increasing)-555.9(maternal)-555.2(hypoglycemia.)]TJ
T*
[(Beyond)-319.8(impacting)-319.1(surrogate)-323.1(markers)-322(of)-313.2(maternal)-324.8(glycemia,)]TJ
0 -1.1174 TD
[(using)-201.3(CGM)-196.2(led)-200.4(to)-198.2(clinically)-199.5(signicant)-203.4(reductions)-203.4(in)-198.2(large)-198(for)]TJ
0 -1.1116 TD
[(gestational-age)-212.7(infants,)-208.2(neonatal)-208.4(hypoglycemia,)-211.7(and)-206.1(neonatal)]TJ
T*
[(intensive)-225.5(care)-226.7(unit)-223.5(\(NICU\))-228.2(admissions.)]TJ
7.3823 0 0 6.5614 215.2062 488.3526 Tm
(7)Tj
9.843 0 0 9.843 221.0456 483.9873 Tm
[(A)-226.6(systematic)-228.8(review)]TJ
-16.156 -1.1174 TD
[(combining)-404.2(data)-404.3(from)-403(CONCEPTT)-407.7(with)-408.7(that)-403.2(of)-399.6(the)-407.8(type)-403.1(1)]TJ
0 -1.1116 TD
[(diabetes)-254.3(arm)-259.1(of)-249.8(the)-252.3(GlucoMOMS)-256.5(trial)-254.7(also)-253.2(showed)-256.1(evidence)]TJ
T*
[(for)-239.4(a)-232.6(reduction)-242.9(in)-238.5(preeclampsia.)]TJ
7.3823 0 0 6.5614 186.9165 455.4707 Tm
(79)Tj
9.843 0 0 9.843 200.296 451.1054 Tm
[(This)-241.7(is)-238.3(important)-237.3(because)]TJ
-14.0479 -1.1174 TD
[(preeclampsia)-279.5(and)-269.4(its)-274.1(consequences)-272.1(of)-272.9(growth)-272.5(restriction)-273.9(and)]TJ
0 -1.1116 TD
[(preterm)-454.8(births)-455.9(are)-454.8(associated)-453.3(with)-454.8(substantial)-458.1(mother)-452.6(and)]TJ
T*
[(infant)-370.9(morbidity)-368.6(and)-367.3(mortality)-369.9(globally.)-370.9(Mother)-365.9(and)-373.1(infant)]TJ
T*
[(deaths)-371.7(account)-368.4(for)-366.1(6%7%)-364.7(of)-365(all)-367.6(deaths)-366(globally,)-370.9(approxi-)]TJ
0 -1.1174 TD
[(mately)-189(half)-190(of)-192.2(the)-188.9(global)-186.6(burden)-192.1(of)-186.5(deaths)-193.2(caused)-194.2(by)-186.5(cancer.)]TJ
7.3823 0 0 6.5614 293.7259 400.6487 Tm
(10)Tj
9.843 0 0 9.843 72 385.3416 Tm
-.0158 Tc
[(A)-570.7(T)-15.8(e)8.4(c)-.8(hno)-15.8(l)10.7(ogy)-575.6(App)-15.8(r)10.8(ais)-15.8(a)9.8(l)-570(f)-15.8(r)10.9(o).4(m)-576.8(N)-.5(ati)-15.8(o)10.7(nal)-575.7(H)-.5(eal)-15.8(t)10.5(h)-569.8(S)-15.8(e)9.8(rvi)-15.8(c)9.5(e)]TJ
-1.0137 -1.1116 TD
-.0159 Tc
[(\(N)-15.9(H)9(S).4(\))-270.4(W)-2(a)-15.9(l)9.4(es)-270.2(r)-15.9(e)9.6(por)-15.9(t)10.6(e)-.9(d)-270.4(t)-15.9(h)10.6(a)-.9(t)-270.6(C)-.7(G)-15.9(M)-261.8(use)-277.3(i).2(mpro)-15.9(v)10.7(e)-.9(s)-270.2(g)-15.9(l)10.6(y).3(ce)-15.9(m)8.3(i).2(c)-271.6(c)-.9(on)-15.9(-)]TJ
0 -1.1174 TD
0 Tc
[(t)16.1(r)0(o)26.6(l)16.1(,)-354.8(r)16.2(e)15(d)16.2(uc)25.4(e)15(s)-352.2(t)16.1(h)16.2(e)-353.6(i)0(n)26.5(c)15(i)16.1(d)16.2(en)25.4(c)15(e)-353.6(o)16.2(f)-352.4(p)16.2(r)0(e)25.5(e)15(c)15(l)16.1(am)24.2(p)16.2(s)16.4(ia)-337.5(an)25.4(d)-352.4(n)16.2(e)15(o)16.2(na)25.4(t)16.1(a)15(l)-352.6(h)16.2(y-)]TJ
0 -1.1116 TD
-.016 Tc
[(po)-16(g)10.6(l).1(yce)-16(m)8.2(ia,)-301.7(a)-16(n)9.4(d)-305.1(redu)-16(c)9.4(e)-1(s)-304.9(a)-1(dmis)-16(s)11(i).1(o)-16(n)-288.9(t)-16(o)-289(a)-16(n)9.4(d)-305.1(durat)-16(i)10.3(on)-305.1(of)-305.1(st)-16(a)9.3(y)-305.1(in)]TJ
T*
-.0158 Tc
[(neo)-15.8(n)10.8(ata)-15.8(l)-278.5(inte)-15.8(n)9.6(s).6(iv)-15.8(e)-278.3(care)-15.8(.)]TJ
7.3823 0 0 6.5614 152.6173 345.8834 Tm
0 Tc
(8)Tj
9.843 0 0 9.843 159.0236 341.518 Tm
-.0158 Tc
[(All)-293.5(NHS)-287.4(Tr)-15.8(u)10.8(s).6(ts)-293.2(must)-287.7(n)-15.8(o)10.8(w)-288.5(a)-.8(do)-15.8(p)10.8(t)-287.7(thi)-15.8(s)]TJ
-9.8549 -1.1174 TD
-.0159 Tc
[(gu)-15.9(i)10.6(d).3(anc)-15.9(e)8.4(,)-255.5(a)-.9(nd)-258.9(if)-253.1(n)-15.9(o)10.7(t,)-255.5(th)-15.9(e)9.5(y)-253.1(ar)-15.9(e)-243.9(r).3(eq)-15.9(u)10.7(i).2(re)-15.9(d)-243.9(t).2(o)-258.9(j).2(us)-15.9(t)10.8(i).2(fy)-258.9(why)-258.9(i).2(t)-253.3(h)-15.9(a)9.5(s)-252.9(no)-15.9(t)]TJ
0 -1.1116 TD
-.0158 Tc
[(bee)-15.8(n)-255.3(foll)-15.8(o)10.7(wed.)]TJ
7.3823 0 0 6.5614 118.885 323.9432 Tm
-.0162 Tc
(11)Tj
9.843 0 0 9.843 128.5795 319.5779 Tm
.2488 Tc
[(B)264(a)248.8(s)274.4(e)263.8(do)265(nt)248.8(h)275.3(e)-1.1(d)265(a)263.8(t)264.9(a)-1.1(f)248.8(r)275.5(o)265(m)-1.2(C)264(O)264.1(N)264.1(C)248.8(E)273.2(P)265.1(T)263.8(T)-1.2(a)263.8(n)265(dt)248.8(h)275.3(e)]TJ
-6.7619 -1.1116 TD
-.0159 Tc
[(re)-15.9(a)8.4(l).2(-wo)-15.9(r)10.7(ld)-402.9(he)-15.9(a)8.4(lth)-402.9(ou)-15.9(t)10.6(c)-.9(omes)-402.7(o)-15.9(f)-392.4(preg)-15.9(n)10.7(ant)-403(w)-.6(om)-15.9(e)8.3(n)-402.9(with)-402.9(ty)-15.9(p)10.7(e)-404.1(1)]TJ
T*
[(di)-15.9(a)9.4(b).3(ete)-15.9(s)-249.5(and)-258.9(t).2(he)-15.9(i)9.4(r)-258.9(newb)-15.9(o)10.7(rns)-258.7(i)-15.9(n)-242.9(t)-15.9(h)10.6(e)-260.1(S).4(wed)-15.9(i)10.6(sh)-258.9(st)-15.9(u)10.6(dy,)-261.2(the)-260.1(U)-.6(K)-259.8(N)-15.9(a)8.7(-)]TJ
0 -1.1174 TD
0 Tc
[(t)16.1(i)0(o)26.5(n)16.2(a)15(l)-202.8(I)16.2(n)16.2(s)0(t)26.7(i)16.1(t)16.1(u)0(t)26.5(e)-198.1(fo)26.6(r)-202.7(H)15.3(e)15(a)15(l)16.1(th)-186.6(a)15(n)0(d)-186.5(C)15.2(li)26.3(n)16.2(i)16.1(c)15(a)0(l)-187.8(E)15(xc)25.4(e)15(l)16.1(l)16.1(e)0(n)25.4(c)15(e)-203.8(\()16.2(N)15.3(I)16.2(C)15.2(E)0(\))-187.7(h)16.2(av)25.4(e)]TJ
0 -1.1116 TD
-.0159 Tc
[(al)-15.9(s)10.8(o)-247.4(r)-15.9(e)9.6(vie)-15.9(w)8.7(ed)-253.1(their)-253.1(d).3(i)-15.9(a)9.4(bete)-15.9(s)-237.9(p)-15.9(r)10.7(e)-.9(gna)-15.9(n)9.5(c)-.9(y)-253.1(guid)-15.9(e)9.5(lin)-15.9(e)9.5(s)-247.2(\()-15.9(T)9.5(able)-254.3(2\))-15.9(.)]TJ
1.0137 -1.1116 TD
0 Tc
[(The)-305.2(NICE)-307(guidelines)-313(were)-307.1(updated)-309.7(in)-301.8(December)-315(2020)-303.9(to)]TJ
-1.0137 -1.1174 TD
[(recommend)-378.7(that)-374.4(real-time)-377.8(CGM)-374.7(be)-377.7(offered)-372.8(to)-376.7(all)-373.3(pregnant)]TJ
0 -1.1116 TD
[(women)-198.8(with)-201.4(type)-201.5(1)-196.9(diabetes.)]TJ
7.3823 0 0 6.5614 173.1968 247.2377 Tm
(12)Tj
9.843 0 0 9.843 182.5511 242.8724 Tm
[(All)-200.3(pregnant)-201.3(women)-204.6(with)-195.6(type)]TJ
-12.2451 -1.1116 TD
[(1)-369.7(diabetes)-375.2(will)-368.5(receive)-375.3(government-funded)-374.8(real-time)-372.1(CGM)]TJ
0 -1.1174 TD
[(for)-279.7(up)-284.4(to)-278.8(12)-284.4(months)-278.5(of)-284.4(duration,)-284.3(meaning)-282.1(that)-282.3(they)-282.2(can)-282.1(con-)]TJ
0 -1.1116 TD
[(tinue)-392.8(CGM)-392(use)-390.2(beyond)-393.7(pregnancy)-393.5(into)-390.6(the)-390.5(early)-393.8(postnatal)]TJ
T*
[(period.)-305(They)-300.5(also)-299.2(advise)-302.6(that)-299.6(a)-301.8(member)-305.1(of)-301.7(the)-298.3(clinical)-306.6(team)]TJ
0 -1.1174 TD
[(with)-356.9(expertise)-364.8(in)-359.4(CGM)-357.4(and)-361.6(ash)-356.6(should)-357.9(provide)-360.3(education)]TJ
0 -1.1116 TD
[(and)-223.3(support,)-224.2(including)-224.6(advising)-223.2(women)-227.6(about)-219.9(sources)-228.5(of)-221(out-)]TJ
T*
[(of-hours)-308(support.)-304.8(A)-307.2(list)-309.9(of)-301.7(web)-310.6(resources)-306.7(for)-308.5(providing)-303.9(out-)]TJ
T*
[(of-hours)-187.1(support)-186.2(is)-180.7(provided.)-186.3(This)-184.1(is)-186.4(a)-186.6(potential)-185.5(game)-186.5(changer)]TJ
0 -1.1174 TD
[(for)-423.7(pregnant)-420.2(women)-423.5(with)-420.2(type)-420.4(1)-421.6(diabetes)-421.3(and)-424.9(health)-418.1(care)]TJ
0 -1.1116 TD
[(professionals,)-284.6(in)-278.8(the)-286.8(United)-279.6(Kingdom)-280.6(and)-280.9(beyond.)]TJ
1.0137 -1.1116 TD
[(In)-318.9(addition)-327.1(to)-324.9(randomized-controlled)-330.1(trial)-323.8(evidence,)-322.3(real-)]TJ
-1.0137 -1.1174 TD
[(world)-357.8(data)-364(on)-359.3(the)-355.9(use)-361.4(of)-359.3(real-time)-360.5(CGM)-363.2(and)-355.8(ash)-362.3(glucose)]TJ
0 -1.1116 TD
[(monitoring)-196.9(in)-192.4(type)-195.8(1)-191.2(diabe)-8(tes)-194.5(pregnancies)-195.2(have)-196.8(conrmed)-196.5(the)]TJ
T*
[(association)-678(between)-668.8(CGM)-674.2(measures)-675.5(and)-666.8(neona)-7.8(tal)-667.1(out-)]TJ
0 -1.1174 TD
(comes.)Tj
7.3823 0 0 6.5614 89.6882 82.885 Tm
(13)Tj
9.843 0 0 9.843 99.0425 78.463 Tm
[(A)-192(Swedish)-193.8(study)-195.5(of)-192.2(186)-193.4(women)-198.8(described)-197.6(the)-194.7(use)-194.3(of)]TJ
-3.7611 -1.1116 TD
[(real-time)-326(CGM)-322.9(\(Dexcom)-323.1(G4\))-326.7(and)-321.2(ash)-322(glucose)-321(monitoring)]TJ
T*
[(\(FreeStyle)-440.6(Libre\))-435.3(in)-434.3(type)-437.7(1)-433.1(diabetes)-438.6(pregnancies.)-440.6(Authors)]TJ
25.504 42.3166 TD
[(demonstrated)-242.6(that)-236.2(a)-232.6(higher)-238.3(CGM)-236.5(TIR)-235.9(in)-232.7(the)-235(second)-239.1(and)-234.9(third)]TJ
0 -1.1116 TD
[(trimesters)-291(was)-293.1(associated)-292(with)-287.8(a)-284.5(decreased)-292(risk)-286.5(of)-290.2(large-for-)]TJ
0 -1.1174 TD
[(gestational)-10.2(-age)-283.2(and)-286.7(a)-284.5(decreased)-286.2(risk)-286.5(of)-284.4(their)-283.4(composite)-290(neo-)]TJ
0 -1.1116 TD
[(natal)-589.8(outcome)-593.1(\(shoulder)-586.9(dystocia,)-590.6(macrosomia,)-596.3(neonatal)]TJ
T*
[(hypoglycemia,)-200.2(and)-194.5(neonatal)-191.1(intens)-7.8(ive)-188.9(care)-197.9(admission\).)-195.2(When)]TJ
T*
[(taken)-411.1(together,)-412.2(these)-410.9(randomized-controlled)-416.5(trial)-410.2(and)-407.6(real-)]TJ
0 -1.1174 TD
[(world)-329(data)-323.6(suggest)-325.4(that)-322.6(increasing)-325.6(TIR)-328(by)-319(5%)-325.8(is)-324.7(associated)]TJ
0 -1.1116 TD
[(with)-282(clinically)-285.9(meaningful)-285.5(improvements)-283(in)-278.8(outcomes.)]TJ
7.3823 0 0 6.5614 530.8156 400.7621 Tm
(7,13)Tj
9.843 0 0 9.843 323.0361 385.455 Tm
-.0234 Tc
[(Data)-221.5(regard)4.3(in)4.3(g)-226.1(t)-1.6(h)4.3(e)-227.2(us)4.5(e)-227.2(o)4.3(f)-226.1(C)-2.5(GM)-227(in)-226.1(p)4.3(r)-1.4(eg)4.3(nant)-226.2(women)-220.3(w)-2.3(i)4.2(t)-1.6(h)-226.1(t)4.2(yp)4.3(e)]TJ
-1.0137 -1.1174 TD
-.0275 Tc
[(2)-230.2(d).2(i)-5.7(a)-1(be)-6.7(te)-6.7(s)-224.2(a)-1(r)-5.5(e)-225.6(s)-5.4(t).1(i)-5.7(l).1(l)-224.6(l)-5.7(im)-6.8(it)-5.7(ed.)-226.8(T)-1(h)-5.6(r).2(e)-6.7(e)-225.6(ra)-6.7(nd)-5.6(om)-6.8(iz)-6.7(ed)-224.4(t)-5.7(r).2(i)-5.7(a)-1(l)-5.7(s)-224.2(pe)-6.7(rf)-5.5(or)-5.5(me)-6.7(d)-224.4(i).1(n)]TJ
0 -1.1116 TD
-.0226 Tc
[(th)5.1(e)-370.4(U)4.2(n)5.1(i)-.8(t)5(e)-1.8(d)-363.5(K)4.2(in)5.1(gd)5.1(om,)-365.8(D)4.2(en)5.1(mark)5.1(,)-365.9(a)3.9(nd)-363.5(t)5(h)-.7(e)-364.7(N)4.2(et)5(herl)5(an)5.1(ds)-363.3(i)5(n)-.7(clu)5.1(d)-.7(ed)]TJ
T*
-.0228 Tc
[(preg)4.9(nant)-415.7(wo)4.9(men)-421.3(w)4(it)4.8(h)-421.3(b)4.9(ot)4.8(h)-421.3(t)4.8(yp)4.9(e)-422.5(1)-415.6(an)4.9(d)-421.3(t)-1(y)4.9(p)4.9(e)-422.5(2)-421.3(d)4.9(iabet)4.8(e)-2(s.)]TJ
7.3823 0 0 6.5614 531.496 356.9385 Tm
-.0322 Tc
[(9)7(,)-4.9(14,15)]TJ
9.843 0 0 9.843 313.0582 341.5747 Tm
-.0226 Tc
[(Ho)5.1(wever,)-314(o)5.1(n)-.7(l)5(y)-311.7(smal)5(l)-311.8(n)-.7(u)5.1(m)-1.9(b)5.1(e)-1.8(r)5.1(s)-311.5(of)-311.6(pr)5.1(eg)5.1(nant)-311.8(women)-311.7(w)4.2(it)5(h)-317.4(t)5(y)5.1(p)-.7(e)-312.8(2)]TJ
T*
-.0223 Tc
[(di)5.3(ab)5.4(et)5.3(es)-420.6(were)-422(in)5.4(cl)5.3(ud)5.4(ed)-426.6(\()5.4(3)-.4(5)5.4(%)-1.4(,)-423.1(2)5.4(0%,)-423.1(a)-1.5(n)5.4(d)-426.6(2)5.4(7)-.4(%)-421.9(f)5.4(or)-420.8(th)5.4(e)-427.7(U)4.5(ni)5.3(ted)]TJ
T*
-.0226 Tc
[(Ki)5(ng)5.1(do)5.1(m,)-429.2(Den)5.1(m)-1.9(ark)5.1(,)-429.2(an)5.1(d)-432.6(t)5(he)-433.8(Neth)5.1(er)5.1(land)5.1(s,)-429.2(resp)5.1(ecti)5(vel)5(y)-.7(\).)]TJ
7.3823 0 0 6.5614 531.496 324.0566 Tm
-.0322 Tc
[(9)7(,)-4.9(14,15)]TJ
9.843 0 0 9.843 313.0582 308.6928 Tm
-.0274 Tc
[(F)-5.3(u).3(r)-5.4(t)-5.6(her)-5.4(m)-.9(o)-5.5(r).3(e)-6.6(,)-353.4(th)-5.5(e)-352.2(U)-.6(K)-351.9(a)-6.6(nd)-356.8(Dut)-5.6(c)-.9(h)-356.8(s).5(t)-5.6(u).3(d)-5.5(i).2(e)-6.6(s)-350.8(us)-5.3(ed)-356.8(ol)-5.6(de)-6.6(r)-351(g).3(e)-6.6(n).3(e)-6.6(r).3(a)-6.6(t).2(i)-5.6(o).3(n)]TJ
T*
-.0272 Tc
[(m)-6.5(a)-.7(s)-5.1(k).5(e)-6.4(d)-350.8(C)-6.3(G)-.4(M)-357.5(s).7(e)-6.4(n).5(s)-5.1(o).5(r)-5.2(s)-356.4(\(k)-5.3(no)-5.3(wn)-356.6(as)-356.4(pr)-5.2(of)-5.2(es)-5.1(s)-5.1(i).4(o)-5.3(n).5(al)-356.7(o)-5.3(r)-350.8(r)-5.2(e)-.7(t)-5.4(r).5(o)-5.2(s).7(p)-5.3(e)-.7(c)-6.4(t).4(i)-5.4(v).5(e)]TJ
T*
-.0274 Tc
[(C)-6.5(G)-.6(M)-6.4(\))-258.9(and)-258.9(t)-5.6(he)-260(Da)-6.6(ni)-5.6(sh)-258.9(s)-5.3(t).2(u)-5.5(d).3(y)-258.9(u).3(s)-5.3(e)-.9(d)-258.9(r)-5.4(eal)-5.6(-t)-5.6(im)-6.7(e)-254.3(C)-6.5(GM)-259.8(in)-5.5(te)-6.6(rm)-6.7(it)-5.6(te)-6.6(nt)-5.6(ly)]TJ
T*
-.0226 Tc
[(rath)5.1(er)-277.1(th)5.1(an)-282.9(co)5.1(nt)5(in)5.1(uo)5.1(us)5.3(ly)-277.1(th)5.1(ro)5.1(ug)5.1(ho)5.1(ut)-277.3(p)5.1(r)-.6(egn)5.1(a)-1.8(n)5.1(c)3.9(y.)]TJ
7.3823 0 0 6.5614 491.6975 280.233 Tm
-.0322 Tc
(14,15)Tj
9.843 0 0 9.843 323.0361 264.8692 Tm
0 Tc
[(Only)-443.1(the)-436.6(UK)-441.7(study)-437.4(published)-443.1(details)-442.2(of)-434.1(the)-442.3(gestational)]TJ
-1.0137 -1.1116 TD
[(chang)-7.8(es)-475.5(in)-474.6(CGM)-478.4(glucose)-482.3(proles)-475.2(during)-479(type)-478(2)-473.4(diabetes)]TJ
T*
[(pregnancy)-445.4(showing)]TJ
/F10 1 Tf
8.438 0 TD
(*)Tj
/F5 1 Tf
1.0022 0 TD
[(60%)-436.3(TIR)-443.2(during)-432.9(the)-442.3(rst)-436.1(trimester,)]TJ
-9.4402 -1.1174 TD
[(rising)-260.1(to)-261.5(65%)-257.8(in)-261.5(the)-258(second)-262.2(and)-257.9(75%)-257.8(in)-255.8(the)-263.8(third)-259.2(trimester.)]TJ
7.3823 0 0 6.5614 544.8187 236.4094 Tm
(16)Tj
9.843 0 0 9.843 313.0582 221.0456 Tm
[(In)-405.3(contrast)-408.6(to)-405.5(women)-411.9(with)-403(type)-408.9(1)-404.3(diabetes,)-407.5(who)-407.4(had)-407.6(only)]TJ
0 -1.1116 TD
[(modest)-279.6(reductions)-284.1(in)-273(TAR,)-280.5(women)-279.5(with)-276.2(type)-276.4(2)-277.6(diabetes)-283.1(had)]TJ
0 -1.1174 TD
[(substantial)-394.7(gestational)-396.1(improvements)-398.2(in)-388.2(TAR)-392.3(from)]TJ
/F10 1 Tf
21.4607 0 TD
(*)Tj
/F5 1 Tf
1.0022 0 TD
(33%)Tj
-22.4629 -1.1116 TD
[(\(8)-169.2(h/day\))-330.4(in)-324.9(trimester)-324.6(1,)-327.1(20%)-326.9(\(4.8)-168(h/day\))-324.7(in)-324.9(trimester)-330.4(2,)-327.1(and)]TJ
T*
[(12%)-240.5(\(3)-163.4(h/day\))-238.3(in)-232.7(trimester)-238.2(3.)]TJ
7.3823 0 0 6.5614 425.707 181.5874 Tm
(16)Tj
9.843 0 0 9.843 435.4015 177.222 Tm
[(The)-236(reduced)-235.8(fetal)-238.4(exposure)-235.5(to)]TJ
-12.4294 -1.1116 TD
[(maternal)-601.3(hyperglycemia)-602.2(likely)-595.6(explains)-598.7(the)-597.8(signicantly)]TJ
0 -1.1174 TD
[(lower)-744.9(rates)-739.2(of)-739.4(preterm)-742.8(births,)-741.6(large-for-gestational-age)]TJ
0 -1.1116 TD
[(birthweight)-325.7(infants,)-323.4(and)-321.3(neonatal)-323.6(intensive)-323.5(care)-318.9(unit)-321.5(admis-)]TJ
T*
[(sions)-281.7(in)-284.5(type)-282.2(2)-277.6(diabetes)-283.1(offspring.)]TJ
1.0137 -1.1174 TD
[(While)-291.4(the)-292.6(achievement)-290.1(of)-290.1(glucose)-292.2(targets)-292.3(in)-290.3(pregnancy)-289.8(is)]TJ
-1.0137 -1.1116 TD
[(more)-219.9(common)-217.6(in)-215.4(women)-221.9(with)-218.6(type)-213(2)-220(diabetes)-219.7(compared)-220.8(with)]TJ
T*
[(those)-306.1(with)-299.3(type)-305.2(1)-300.6(diabetes,)-303.8(it)-302(would)-300.3(be)-302.9(a)-301.8(mistake)-305.1(to)-301.8(assume)]TJ
0 -1.1174 TD
[(that)-403.2(type)-403.1(2)-398.5(diabetes)-404(is)-399.6(a)-399.7(milder)-400.9(or)-399.6(less)-402.7(serious)-400.2(concern)-402.8(in)]TJ
0 -1.1116 TD
[(pregnancy.)-310.6(It)-307.6(is)-307.4(possible)-303.6(that)-311.1(tighter)-308.7(glucose)-303.7(targets)-309.6(may)-305.2(be)]TJ
T*
[(needed)-465.1(for)-458.3(optimal)-459.8(pregnancy)-462.6(outcomes)-461.6(in)-457.3(type)-460.7(2)-456.1(diabe-)]TJ
0 -1.1174 TD
(tes.)Tj
7.3823 0 0 6.5614 326.4944 61.0583 Tm
(17)Tj
9.843 0 0 9.843 337.6062 56.6362 Tm
[(The)-374.3(recent)-373.1(international)-375.5(consensus)-380.3(for)-371.9(CGM-derived)]TJ
ET
313.058 689.556 239.131 .28345 re
f
313.058 513.864 239.131 .28345 re
f
BT
/F7 1 Tf
9.845 0 0 9.845 339.8172 725.1588 Tm
(Table)Tj
/F5 1 Tf
3.0002 0 TD
(2.)Tj
/F7 1 Tf
1.2496 0 TD
[(Summary)-337.8(of)-331.2(National)-337.8(Institute)]TJ
-5.8276 -1.0135 TD
[(for)-338(Health)-330.2(and)-337.8(Clinical)-332.7(Excellence)-334.5(Guideline)]TJ
-.5125 -1.0135 TD
[(Recommendations)-336.2(for)-332.2(Use)-337.6(of)-331.2(Continuous)-337.7(Glucose)]TJ
5.6031 -1.0077 TD
[(Monitoring)-335.4(in)-331.6(Pregnancy)]TJ
/F5 1 Tf
-6.2307 -1.5894 TD
[(Offer)-340.9(CGM)-333.8(to)-330.4(all)-338.5(pregnant)-332.9(women)-336.3(with)-333.4(type)-333.5(1)-335(diabetes)-334.1(to)]TJ
.9962 -1.0135 TD
[(help)-264.4(them)-265.6(meet)-261(their)-265.6(pregnancy)-265.8(blood)-264.3(glucose)-268.4(targets)-268.6(and)]TJ
T*
[(improve)-331.9(neonatal)-340(outcomes.)]TJ
-.9962 -1.0135 TD
[(Offer)-254.6(intermittently)-248.9(scanned)-246.4(CGM)-247.5(\(commonly)-248.7(referred)-253.3(to)-244(as)]TJ
.9962 -1.0077 TD
[(ash\))-334(to)-330.4(pregnant)-338.7(women)-336.3(with)-333.4(type)-333.5(1)-335(diabetes)-334.1(who)-332(are)]TJ
0 -1.0135 TD
[(unable)-330.9(to)-336.2(use)-332.2(CGM)-339.6(or)-330.2(express)-337.2(a)-336.2(clear)-336.9(preference)-338.2(for)-331.2(it.)]TJ
-.9962 -1.0135 TD
[(Consider)-338.3(CGM)-333.8(for)-337(pregnant)-332.9(women)-336.3(who)-332(are)-339.3(on)-330.2(insulin)]TJ
.9962 -1.0077 TD
[(therapy)-331.9(but)-337.1(do)-330.2(not)-337.1(have)-334.5(type)-333.5(1)-335(diabetes,)-331.7(if:)]TJ
0 -1.0135 TD
[(They)-334.5(have)-334.5(problematic)-338.6(severe)-331.8(hypoglycemia)-339.4(\(with)-334.4(or)]TJ
T*
[(without)-330.8(impaired)-340(awareness)-336.6(of)-336(hypoglycemia\))-334.6(or)]TJ
T*
[(They)-311.5(have)-317.3(unstable)-315.6(blood)-310.3(glucose)-314.5(levels)-319.4(that)-310.7(are)-316.3(causing)]TJ
0 -1.0077 TD
[(concern)-332.9(despite)-337.7(efforts)-336.3(to)-330.4(optimize)-340.2(glycemic)-335.4(control.)]TJ
-.9962 -1.0135 TD
[(For)-336.8(pregnant)-332.9(women)-336.3(who)-332(are)-339.3(using)-333.2(intermittently)-335.3(scanned)]TJ
.9962 -1.0135 TD
[(CGM)-333.8(or)-330.2(CGM,)-337.2(a)-336.2(member)-333.1(of)-336(the)-332.6(joint)-333.7(diabetes)-339.8(and)]TJ
T*
[(antenatal)-244.5(care)-249.3(team)-243.8(with)-241.2(expertise)-248.7(in)-244(these)-243.4(systems)-245(should)]TJ
0 -1.0077 TD
[(provide)-232.9(education)-237.4(and)-240.2(support)-231.5(\(including)-241.9(advising)-233.8(women)]TJ
0 -1.0135 TD
[(about)-334.5(sources)-331.4(of)-336(out-of-hours)-334.4(support\).)]TJ
8.7511 0 0 8.7511 321.0519 502.0723 Tm
[(CGM,)-396.3(continuous)-393.5(glucose)-399.5(monitoring;)-392.9(NICE,)-399.1(National)-393.2(Institute)]TJ
-.9135 -1.0236 TD
[(for)-337(Health)-332(and)-334.5(Clinical)-333.8(Excellence.)]TJ
/F4 1 Tf
8.9663 0 0 8.9663 62.022 749.6502 Tm
(S-10)Tj
41.5731 0 TD
[(YAMAMOTO)-341(AND)-330.9(MURPHY)]TJ
ET
endstream
endobj
42 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
9.843 0 0 9.843 59.7543 483.9873 Tm
0 0 0 rg
0 Tc
0 Tw
[(glycemic)-440(targets)-442(suggested)-438.2(that)-437.8(90%)-436.3(TIR)-431.7(3.57.8)-167.9(mmol/L)]TJ
0 -1.1174 TD
[(\(63140)-169(mg/dL\))-383.5(may)-385.8(be)-383.5(applicable)-384.7(with)-385.7(no)-382.3(more)-386.9(than)-380.1(5%)]TJ
0 -1.1116 TD
[(TAR,)-378.5(and)-373.1(4%)-377.6(time)-375.7(below)-370.5(range)-376.4(\(TBR\))-377.3(may)-374.3(be)-377.7(applicable)]TJ
T*
[(during)-265.9(type)-259.1(2)-260.3(diabetes)-265.8(pregnancy)-261(\(Fig.)-261.2(1\).)]TJ
7.3823 0 0 6.5614 225.8645 455.4707 Tm
(18)Tj
9.843 0 0 9.843 235.8424 451.1054 Tm
[(However,)-262.9(given)]TJ
-17.8896 -1.1174 TD
[(the)-304.1(paucity)-298.3(of)-301.7(CGM)-299.9(data)-300.6(and)-298.2(no)-295.9(studies)-302.5(describing)-301.4(associa-)]TJ
0 -1.1116 TD
[(tions)-322.4(with)-322.3(pregnancy)-324.4(outcome,)-325.9(there)-324.7(are)-322.4(no)-319(evidence-based)]TJ
T*
[(recommendation)-11.3(s)-283.1(i)0(n)-284.5(type)-287.9(2)-283.3(diabetes)-288.8(pregnancy.)]TJ
7.3823 0 0 6.5614 249.6755 422.5889 Tm
(18)Tj
9.843 0 0 9.843 259.8802 418.2235 Tm
[(Given)-284.1(the)]TJ
-20.3318 -1.1116 TD
[(global)-255.7(increase)-255.3(in)-250(type)-247.6(2)-248.8(diabetes)-254.3(pregnancy)-255.3(and)-252.1(widespread)]TJ
0 -1.1174 TD
[(availability)-345.8(of)-336.2(more)-340.8(affordable)-342.8(user-friendly)-344.9(CGM)-340.2(devices,)]TJ
0 -1.1116 TD
[(data)-191.2(regarding)-190.9(the)-194.7(pregnancy)-191.9(outcomes)-190.9(and)-188.8(costs)-190.7(and)-188.8(benets)]TJ
T*
[(of)-330.5(CGM)-328.7(use)-326.8(in)-330.6(this)-327(marginalized)-330.5(patient)-333(population)-329.4(are)-328.1(ur-)]TJ
0 -1.1174 TD
[(gently)-284.5(needed.)]TJ
1.0137 -1.1116 TD
[(While)-383.6(CGM)-386.3(may)-380.1(also)-379.9(have)-386.9(potential)-381.4(for)-383.4(pregnancies)-385.3(in)]TJ
-1.0137 -1.1116 TD
[(individuals)-462.9(with)-460.6(gestational)-465.2(diabetes,)-465.1(evidence)-462.9(supporting)]TJ
0 -1.1174 TD
[(the)-476.9(use)-470.8(of)-474.5(real-time)-475.7(CGM)-472.6(remains)-471.9(limited.)-474.8(Randomized-)]TJ
0 -1.1116 TD
[(controlled)-486(trial)-485.1(evidence)-480.1(in)-480.4(gestational)-488.2(diabetes)-484.7(has)-482.3(been)]TJ
T*
[(limited)-344.7(to)-336.4(the)-338.7(use)-338.3(of)-342(retrospective)-341.6(or)-336.2(intermittent)-345.8(CGM.)]TJ
7.3823 0 0 6.5614 285.959 313.0015 Tm
(9,19)Tj
9.843 0 0 9.843 59.7543 297.6944 Tm
[(Additional)-474.4(trials)-474.5(are)-472.1(needed)-476.6(to)-468.9(determine)-475.6(if)-474.6(women)-475.3(with)]TJ
0 -1.1174 TD
[(gestational)-332.7(diabetes)-329.1(would)-329.1(benet)-325.7(from)-328.1(real-time)-331.7(CGM)-322.9(an-)]TJ
0 -1.1116 TD
[(d/or)-281(ash)-281.7(glucose)-286.4(monitoring.)]TJ
/F4 1 Tf
8.9663 0 0 8.9663 59.7543 248.3716 Tm
[(Using)-262.3(CGM)-254.1(and)-256(Closed-Loop)-259.8(Studies)-257.6(to)-260.7(Understand)]TJ
0 -1.2266 TD
[(How)-334(to)-336.6(Achieve)-333.2(Glucose)-334.6(Targets)]TJ
/F5 1 Tf
9.843 0 0 9.843 69.7323 220.9322 Tm
[(The)-368.5(CONCEPTT)-373.2(and)-367.3(Swedish)-366.6(studie)-7.8(s)-363.8(o)0(f)-365(CGM)-369(in)-370.9(preg-)]TJ
-1.0137 -1.1116 TD
[(nancy)-232.5(demonstrated)-231.1(the)-229.2(gap)-229.1(that)-230.5(currently)-231.3(exists)-226.5(between)-231.1(the)]TJ
T*
[(CGM)-322.9(TIR)-328(targets)-321.1(and)-327(the)-321.4(realities)-324.7(of)-324.7(safely)-319.9(achieving)-330.4(70%)]TJ
0 -1.1174 TD
[(TIR)-356.8(with)-351.1(no)-347.8(more)-352.3(than)-351.3(25%)-349.9(TAR)-352(in)-353.7(type)-351.3(1)-346.7(diabetes)-358(preg-)]TJ
0 -1.1116 TD
(nancy.)Tj
7.3823 0 0 6.5614 85.833 181.474 Tm
(7,13)Tj
9.843 0 0 9.843 102.5574 177.1086 Tm
[(In)-388.1(both)-384.7(studies,)-392.3(women)-388.9(using)-385.6(multiple)-386.1(daily)-387.1(in-)]TJ
-4.3486 -1.1116 TD
[(jections)-305.1(or)-307.4(insulin)-301.6(pump)-299.4(therapy)-303.9(and)-304(with)-305(access)-304.6(to)-301.8(ash)-304.7(or)]TJ
T*
[(CGM)-213.5(only)-211.9(achieved)-209.4(the)-211.9(pregnancy)-215(glucose)-211.6(targets)-211.7(during)-208.3(the)]TJ
0 -1.1174 TD
[(third)-305.2(trimester.)-305(While)-302.9(there)-307.4(is)-301.6(an)-302.9(association)-309.4(between)-305.9(CGM)]TJ
0 -1.1116 TD
[(TIR)-437.5(and)-442.2(fetal)-434.3(complications)-445.6(both)-436.5(at)-435.5(24)-439.9(and)-436.4(at)-435.5(34)-434.2(weeks,)]TJ
T*
[(earlier)-345.5(achievement)-342(of)-342(the)-338.7(pregnancy)-341.7(TIR)-339.6(glucose)-338.3(levels)-343.1(is)]TJ
0 -1.1174 TD
[(needed)-344.2(for)-337.3(optimal)-338.8(neonatal)-340.9(outcomes.)]TJ
7.3823 0 0 6.5614 216.6236 115.7102 Tm
[(7,13)-8.6(,20)]TJ
9.843 0 0 9.843 242.1354 111.3448 Tm
[(It)-342.1(is)-336.2(clear)-343.1(that)]TJ
-18.529 -1.1116 TD
[(the)-258(use)-257.7(of)-255.6(CGM)-253.8(alone)-261.4(is)-255.6(not)-251.1(adequate)-261.3(in)-255.8(achieving)-261.3(glycemic)]TJ
T*
[(targets)-286.5(and)-280.9(reducing)-281.9(complications)-284.3(in)-284.6(pregnancy.)]TJ
1.0137 -1.1174 TD
-.0216 Tc
[(Cl)-5.5(os)-5.2(ed-)-5.4(l).2(oo)-5.4(p)-189.7(i).2(ns)-5.2(ul)-5.5(in)-189.7(de)-6.6(liv)-5.4(ery)-189.7(m)-6.6(ay)-189.7(he)-6.6(lp)-189.7(to)-189.7(f)-5.4(u).3(rt)-5.5(her)-189.7(c)-6.6(los)-5.2(e)-190.9(th)-5.4(e)-185.1(g)-5.4(ap)]TJ
-1.0137 -1.1116 TD
[(b)-5.3(e)-.7(tw)-6.2(een)-201.1(cur)-5.3(r).5(en)-5.3(t)-195.5(a)-.7(nd)-201.1(opt)-5.4(ima)-6.5(l)-195.5(pre)-6.5(gna)-6.5(ncy)-201.1(out)-5.4(com)-6.5(e)-.7(s.)-197.7(Th)-5.3(us)-195.2(f)-5.3(a)-.7(r)-195.4(d).4(a)-6.5(t).3(a)]TJ
T*
-.0175 Tc
[(reg)4.4(a)-2.5(r)4.5(d)-1.3(i)4.3(n)4.4(g)-220.2(t)4.3(he)-215.6(saf)4.5(e)-2.5(t)4.3(y)-220.2(an)4.4(d)-220.2(e)3.3(f)4.6(cacy)-214.4(of)-214.4(cl)4.3(os)4.6(ed-)4.5(l)4.3(oo)4.4(p)-220.2(i)4.3(n)4.4(s)-1.1(u)4.4(l)-1.4(i)4.3(n)-220.2(d)4.4(e)3.3(li)4.3(v)4.4(e)-2.5(r)4.5(y)]TJ
25.5097 43.4224 TD
-.0217 Tc
[(in)-189.8(ty)-5.5(pe)-191(1)-189.8(d).2(i)-5.7(a)-.9(be)-6.7(tes)-189.6(a)-6.7(re)-191(li)-5.7(mit)-5.6(e)-.9(d.)-192.2(Ear)-5.5(l).1(y)-189.8(f).3(e)-6.7(a)-.9(si)-5.6(bi)-5.6(lit)-5.6(y)-189.8(s).4(tu)-5.5(die)-6.7(s)-189.6(con)-5.5(duc)-6.7(ted)]TJ
0 -1.1174 TD
[(und)-5.5(er)-351.1(st)-5.6(ric)-6.7(t)-351.2(exp)-5.5(e)-.9(ri)-5.6(ment)-5.6(al)-351.2(la)-6.7(bor)-5.5(ato)-5.5(r).3(y)-351.1(c)-.9(on)-5.5(di)-5.6(tio)-5.5(ns)-350.9(su)-5.5(gge)-6.7(ste)-6.7(d)-345.3(t)-5.7(h).2(at)]TJ
0 -1.1116 TD
[(clo)-5.5(s).4(e)-6.7(d).2(-l)-5.6(oop)-385.7(sy)-5.5(st)-5.6(ems)-385.5(c)-.9(ou)-5.5(ld)-385.7(sa)-6.7(fel)-5.7(y)]TJ
13.4143 0 TD
-.0198 Tc
[(e)-4.8(s)2.3(ca)-4.8(late)-379.2(overnight)-383.9(b)2.1(asal)-383.9(in-)]TJ
-13.4143 -1.1116 TD
-.0202 Tc
[(sulin)-441.8(de)-5.2(livery)-436(a)-5.2(s)-435.8(p)-4(regnancy)-441.8(ad)]TJ
12.441 0 TD
-.0212 Tc
[(van)-5(ces)-442.6(an)-5(d)-437(t)-5.2(hat)-442.9(C)-.3(G)-5.9(M)-437.9(s)-4.8(e)-.4(n)-5(s).9(or)]TJ
-12.441 -1.1174 TD
-.0217 Tc
[(acc)-6.7(ura)-6.7(c)-.9(y)-230.1(w)-.6(a)-6.7(s)-224.2(a)-6.7(cce)-6.7(pta)-6.7(b).2(le)-231.3(b)-5.5(o).2(th)-230.1(in)-230.1(e)-6.7(a)-.9(rl)-5.7(y)-224.4(a)-6.7(nd)-230.1(in)-230.1(la)-6.7(te)-231.3(ge)-6.7(sta)-6.7(tio)-5.5(n.)]TJ
7.3823 0 0 6.5614 532.6865 444.529 Tm
-.0239 Tc
(21)Tj
9.843 0 0 9.843 541.9274 440.107 Tm
-.022 Tc
(In)Tj
-23.4766 -1.1116 TD
-.0216 Tc
[(add)-5.4(i).2(t)-5.6(i).2(on)-667.8(to)-667.8(ear)-5.4(ly)-662(f)-5.4(eas)-5.2(ib)-5.4(ili)-5.6(ty)-667.8(stu)-5.4(d).3(i)-5.6(e)-.8(s,)-664.4(t)-5.5(w)-.5(o)-667.8(s).5(ma)-6.6(ll)-662.2(c)-6.6(ros)-5.2(so)-5.4(ver)]TJ
T*
-.0172 Tc
[(r)4.8(a)3.6(nd)4.7(omi)4.6(z)3.6(ed)4.7(-co)4.7(n)-1(t)4.6(r)4.8(ol)4.6(l)4.6(e)-2.2(d)-363.9(t)4.6(ri)4.6(als)-363.7(e)3.6(xamin)4.7(i)4.6(ng)-363.9(o)4.7(v)4.7(e)-2.2(r)4.8(n)-1(i)4.6(g)4.7(ht)-364(cl)4.6(os)4.9(ed)4.7(-)4.8(l)-1.2(o)4.7(o)4.7(p)]TJ
T*
-.0217 Tc
[(ins)-5.3(u).2(l)-5.6(i).1(n)-270.5(d).2(e)-6.7(l).1(i)-5.7(v).2(er)-5.5(y)-270.5(a)-.9(nd)-270.5(d)-5.5(a)-.9(y-)-5.5(an)-5.5(d-n)-5.5(i).1(gh)-5.5(t)-270.6(c)-.9(l)-5.6(o).2(se)-6.7(d-l)-5.7(o).2(o)-5.5(p)-270.5(ins)-5.3(u).2(l)-5.6(i).1(n)-270.5(d).2(e)-6.7(liv)-5.5(ery)]TJ
0 -1.1174 TD
-.0181 Tc
[(h)3.8(a)2.7(ve)-319.9(been)-324.5(p)3.8(e)2.7(rf)3.9(o)3.8(r)-1.9(med.)]TJ
7.3823 0 0 6.5614 394.5826 400.6487 Tm
-.0294 Tc
[(22)-5.5(,2)-5.5(3)]TJ
9.843 0 0 9.843 413.4046 396.2834 Tm
-.0215 Tc
[(Th)-5.3(e)-323.3(o).4(v)-5.3(e)-.7(rn)-5.3(ig)-5.3(ht)-322.2(c)-6.5(l).3(os)-5.1(ed-)-5.3(l).3(o)-5.3(o).4(p)-322.1(r)-5.3(an)-5.3(dom-)]TJ
-10.4193 -1.1116 TD
[(ize)-6.6(d)-293.4(cro)-5.4(s).5(s)-5.2(ove)-6.6(r)-293.4(t).2(ri)-5.6(al)-293.5(dem)-6.6(ons)-5.2(tr)-5.4(ate)-6.6(d)-287.6(a)-6.6(n)-293.4(inc)-6.6(r).4(ea)-6.6(se)-294.6(in)-293.4(ov)-5.4(er)-5.4(nig)-5.4(h).3(t)-293.5(T)-.9(I)-5.4(R)]TJ
T*
[(of)-540.9(15%)-542(comp)-5.3(ar)-5.3(ed)-535.2(w)-6.2(ith)-541(se)-6.5(nso)-5.3(r).5(-)-5.3(a)-.7(ug)-5.3(ment)-5.4(ed)-541(pump)-541(t).3(h)-5.3(e)-.7(ra)-6.5(py.)]TJ
7.3823 0 0 6.5614 542.7211 378.7653 Tm
-.0239 Tc
(22)Tj
9.843 0 0 9.843 310.8472 363.4015 Tm
-.0217 Tc
[(Whi)-5.7(l).1(e)-340.7(t).1(he)-340.7(c)-6.7(r).3(os)-5.3(so)-5.5(ver)-339.5(t).1(r)-5.5(i).1(a)-6.7(l)-334(o)-5.5(f)-339.5(day)-5.5(-).3(an)-5.5(d-n)-5.5(i).1(g)-5.5(h).2(t)-339.7(c)-.9(lo)-5.5(se)-6.7(d-l)-5.7(oop)-339.6(i)-5.6(n).2(su)-5.5(lin)]TJ
T*
[(del)-5.5(i).2(v)-5.4(e)-.8(ry)-304.9(di)-5.6(d)-299.2(n).3(o)-5.4(t)-299.3(d)-5.4(e)-.8(mo)-5.4(nst)-5.5(r).4(at)-5.5(e)-300.3(a)-306.1(si)-5.5(gni)-5.6(ca)-6.6(n).3(t)-305.1(i).2(nc)-6.6(rea)-6.6(s).5(e)-306.1(i).2(n)-299.2(T)-6.6(IR)-305.9(in)-299.2(a)]TJ
T*
-.0177 Tc
[(mo)4.2(re)-215.8(di)4.1(v)4.2(e)-2.7(r)4.3(s)-1.3(e)-215.8(g)-1.5(r)4.3(o)4.2(up)-214.6(of)-214.6(par)4.3(t)-1.6(i)4.1(c)3.1(ip)4.2(ant)4.1(s)-220.2(wit)4.1(h)-220.4(h)4.2(i)4.1(gh)4.2(er)-220.4(b)4.2(a)-2.7(s)4.4(e)-2.7(l)4.1(i)4.1(n)-1.5(e)-215.8(H)-2.4(b)4.2(A)3.4(1c,)]TJ
0 -1.1174 TD
-.02 Tc
[(it)-188.3(did)-188.1(s)2.1(how)-189(a)-189.3(signic)-5(ant)-188.3(d)-3.8(ecrease)-189.3(i)]TJ
12.8614 0 TD
.1681 Tc
[(nT)188.8(B)189(R)-1.1(a)183.1(n)190(ds)184.5(i)189.9(g)190(n)184.3(i)189.9()190.2(c)183.1(a)188.9(n)190(t)184.1(l)189.9(yf)190.1(e)183.1(w)189.2(e)188.9(r)]TJ
-12.8614 -1.1116 TD
-.0215 Tc
[(epi)-5.4(s).6(o)-5.3(d).4(es)-281.6(o)-5.3(f)-281.7(hyp)-5.3(ogl)-5.5(yc)-6.5(emia)-6.5(.)]TJ
7.3823 0 0 6.5614 412.4408 323.9432 Tm
-.0315 Tc
(23)Tj
9.843 0 0 9.843 320.8251 308.6361 Tm
0 Tc
[(While)-683.1(early)-687.6(closed-loop)-688.4(insulin)-681.8(delivery)-685.3(studies)-688.4(are)]TJ
-1.0137 -1.1116 TD
[(promising)-201.3(for)-199.1(future)-197.9(clinical)-202.9(care,)-201.4(they)-201.5(also)-201.3(give)-201.5(us)-197.8(additional)]TJ
0 -1.1174 TD
[(insight)-226.8(into)-223.5(the)-229.2(importance)-229.1(of)-226.8(optimizing)-227(diet)-224.7(and)-229.1(exercise)-232.2(in)]TJ
0 -1.1116 TD
[(helping)-349(women)-348.6(to)-342.1(achieve)-352.3(the)-344.4(tight)-351.5(pregnancy)-347.4(glucose)-349.8(tar-)]TJ
T*
[(gets.)-250.8(Stable-label)-260.1(isotope)-250.8(studies)-256.4(demonstrated)-254.1(the)-252.3(relatively)]TJ
0 -1.1174 TD
[(small)-388.1(contribution)-389.3(of)-388.1(decreasing)-390(hepatic)-391.6(insulin)-388(sensitivity)]TJ
0 -1.1116 TD
[(compared)-445.5(with)-443.3(the)-448.1(very)-443.3(substantial)-446.6(increase)-445.3(in)-445.8(peripheral)]TJ
T*
[(insulin)-416.8(resistance,)-422.1(which)-422.4(is)-416.8(essential)-422.3(for)-417.9(postmeal)-421.4(glucose)]TJ
0 -1.1174 TD
(uptake.)Tj
7.3823 0 0 6.5614 339.6472 225.3543 Tm
(24)Tj
9.843 0 0 9.843 350.192 220.9322 Tm
[(Indeed,)-323.4(postmeal)-323.5(glucose)-326.8(disposal)-320.9(is)-318.9(substantially)]TJ
-3.9972 -1.1116 TD
[(delayed)-253.2(in)-255.8(late)-254.7(pregnancy,)-258.7(with)-253.2(weekly)-257.6(delays)-250.8(from)-259(12)-249.9(to)-255.7(16)]TJ
T*
[(weeks)-215.9(onward.)-213.6(This)-218.6(is)-209.5(further)-216.3(exacerbated)-220.8(by)-215.3(delayed)-212.9(insulin)]TJ
0 -1.1174 TD
[(absorption)-334.8(with)-333.8(the)-332.9(time)-335.4(from)-333.9(peak)-335(plasma)-338.4(insulin)-336.2(concen-)]TJ
0 -1.1116 TD
[(tration)-591(increasing)-590.5(from)]TJ
/F10 1 Tf
10.4596 0 TD
(*)Tj
/F5 1 Tf
1.0022 0 TD
[(50)-163.5(min)-592.2(in)-584.1(early)-589.7(pregnancy)-595.1(to)]TJ
-11.4618 -1.1116 TD
[(80)-163.5(min)-281.1(in)-284.6(late)-277.7(pregnancy.)]TJ
7.3823 0 0 6.5614 411.5904 170.5323 Tm
(24)Tj
9.843 0 0 9.843 320.8251 155.2252 Tm
[(The)-299.4(slower)-302.3(achieveme)-11.3(nt)-296.1(of)-301.7(maximal)-306.5(postprandial)-303.7(plasma)]TJ
-1.0137 -1.1174 TD
[(insulin)-313.2(concentration)-318.8(and)-315.5(increased)-319.7(peripheral)-320(insulin)-313.2(resis-)]TJ
0 -1.1116 TD
[(tance,)-386.9(together)-385.7(impede)-390.4(postprandial)-390.1(glucose)-384.4(uptake,)-386.9(facili-)]TJ
T*
[(tating)-267.3(the)-269.5(prolonged)-270.4(duration)-263.6(of)-272.9(postprandial)-269.1(hyperglycemia)]TJ
0 -1.1174 TD
[(in)-290.3(late)-295(pregnancy.)-293.3(Thus,)-291.1(in)-296.1(addition)-292.6(to)-290.3(aggressively)-298.8(increas-)]TJ
0 -1.1116 TD
[(ing)-331.7(premeal)-335.1(boluses)-331.2(to)-336.4(stimulate)-330.6(peripheral)-337.2(muscle)-332.6(glucos)-7.7(e)]TJ
T*
[(uptake,)-473.3(it)-474.8(is)-468.7(also)-477.8(important)-473.4(to)-474.6(administer)-475.5(earlier)-477.9(premeal)]TJ
0 -1.1174 TD
[(boluses)-325.4(as)-320(pregnancy)-324.4(advances.)-327.7(This)-322.3(is)-324.7(as)-319.9(essential)-324.4(for)-325.8(wo-)]TJ
0 -1.1116 TD
[(men)-287.9(using)-287.7(closed-loop)-285.2(as)-291.2(it)-284.7(is)-290.1(in)-284.5(routine)-285.6(clinical)-295(care.)-287.8(How-)]TJ
T*
[(ever,)-280.8(it)-278.9(is)-278.6(further)-279.6(complicated)-283.3(by)-278.7(the)-275.3(fact)-283.3(that)-276.5(unlike)-278.7(outside)]TJ
ET
q
1 i
82.488 732.245 m
527.187 732.245 l
527.187 537.675 l
82.488 537.675 l
W n
q
444.918 0 0 194.57 82.488 537.675 cm
/Im1 Do
Q
Q
BT
/F6 1 Tf
9.845 0 0 9.845 59.7543 520.8943 Tm
[(FIG.)-284.9(1.)]TJ
/F5 1 Tf
4.0655 0 TD
[(Continuous)-281.7(glucose)-285.7(monitoring)-282.2(targets)-280.1(in)-284.3(pregnancy)-283.1(\(Adapted)-281.9(from)-281.5(Battelino)-283.6(et)-285.5(al.)]TJ
7.3837 0 0 6.5625 431.0928 525.2597 Tm
(18)Tj
9.845 0 0 9.845 438.4629 520.8943 Tm
[(\))-283.2(for)]TJ
/F6 1 Tf
2.0616 0 TD
(\(a\))Tj
/F5 1 Tf
1.4512 0 TD
[(type)-281.7(1)-283.2(diabetes)-282.3(and)]TJ
/F6 1 Tf
-41.9798 -1.0077 TD
(\(b\))Tj
/F5 1 Tf
1.5548 0 TD
[(type)-333.5(2)-335(diabetes.)-337.5(*Includes)-333.7(percentage)-338.4(of)-336(values)]TJ
/F8 1 Tf
19.746 0 TD
(<)Tj
/F5 1 Tf
.5528 0 TD
[(3.0)-166.6(mmol/L.)]TJ
/F4 1 Tf
8.9663 0 0 8.9663 59.7543 749.7069 Tm
[(BENEFITS)-336.7(OF)-337.5(REAL-TIME)-336.2(CGM)-336.3(IN)-335.1(PREGNANCY)-29406.1(S-11)]TJ
ET
endstream
endobj
44 0 obj
<>stream
Adobe d
s !1AQa"q2B#R3b$r%C4Scs5D'6Tdt&
EFVU(eufv7GWgw8HXhx)9IYiy*:JZjz m !1AQa"q2#BRbr3$4CS%cs5DT
&6E'dtU7()euFVfvGWgw8HXhx9IYiy*:JZjz ? N*S6*ثb͊6*ثb͊6*ثb͊6*ثb͊6*ثb͊6*ثb͊6*.?E \~.[jm]Wf٪qvjm]Wf٪qvjm]Wf٪qv?y{_.&iaz36*ثb͊6*ثb͊6*ثb͊6*ثb͊6*ثb͊6*ثbHG66&3%ɚ%ed
Hك/AbWf]vlUٱWf]vlUٱWf]vlUٱWf]vlUٱWf]vlUٱWf]vlUٱWf]vlUY{Mor*)M{e0w[N%
bn?i?{f;qOo Sڿ3~ }7_ǽFoӷq F8}Xv?Q+qN?c#7ۏ~8 }G>{f;qOo Sڿ{ߧn?ipWFoӷq F8}Xv?Q+qN?c#7ۏ~8 }G>{akx"Hv)g\IƉ
fk6*ثb͊6*ثb-CW;(n/'